Breakthrough in Chronic Brain Bleed Treatment
New research out of Winnipeg is helping significantly improve treatment for chronic brain bleeds, offering hope to patients suffering from subdural hematomas. The study, led by researchers at the University of Manitoba, focuses on a minimally invasive procedure that reduces the need for surgery and speeds recovery.
Details of the Study
The research involved 200 patients with chronic subdural hematomas, a condition where blood accumulates between the brain and its outer covering. Traditionally, treatment required surgical drainage, which carries risks of recurrence and infection. The new approach uses middle meningeal artery embolization, a technique that blocks the blood supply to the hematoma, allowing it to resolve naturally.
According to Dr. Michael Kelly, a neurosurgeon at the University of Manitoba and lead author of the study, the results were striking: “We saw a 70% reduction in recurrence rates compared to standard surgical treatment. Patients also had shorter hospital stays and fewer complications.”
Impact on Patient Care
The findings are expected to change clinical practice for chronic subdural hematomas, which primarily affect older adults and those on blood thinners. The procedure is performed through a small catheter inserted in the groin, making it less invasive than traditional surgery. Dr. Kelly emphasized that this could become the new standard of care. “This is a game-changer for patients who are often frail and at high risk for surgery,” he said.
The study was published in the New England Journal of Medicine and has already drawn attention from medical centers worldwide. Researchers are now working to expand access to the technique across Canada.
